(April 16, 2024, 11:14 AM EDT) -- WASHINGTON, D.C. — The Food and Drug Administration in an April 15 response brief urges the U.S. Supreme Court to deny a flavored e-liquid maker’s petition for a writ of certiorari, arguing that the high court should instead grant certiorari on the FDA’s separate petition seeking review of an en banc Fifth Circuit U.S. Court of Appeals ruling reversing an FDA ban because that case presents the “full range of legal issues” involved....